Meloxicam

Molecular Formula

Structure

C₁₄H₁₃N₃O₄S₂

Category

Specifications

Antirheumatic (Nonsteroidal anti-inflammatory)

BP2002

Apperance: Pale Yellow Powder

Identification:

A: Comply to standards

B: Comply to standards

Clarity of Solution: Clear

Related substances:

• Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3carboxylate 1,-dioxide ≤ 0.05%

• 5-methylthiazol-2-ylamine ≤ 0.1%

• 4-hydroxy-2-methyl-N-(5-methyl-1, 3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide ≤ 0.05%

• Methyl 4-hydroxy-2-methyl-2H-1, 2-benzothiazine-3-carboxylate 1,1-dioxide ≤ 0.1%

• 4-hydroxy-2-methyl-N-methyl-N- (5-methyl-1, 3-thiazol-2-yl)-2H-1, 2-benzothiazine-3-carboxamide 1,1-dioxide ≤ 0.1%

• Total related substance ≤ 0.3%

Heavy metals ≤ 10 ppm

Loss on drying ≤ 0.5%

Sulphated ash ≤ 0.1%

Assay: 99.0-100.5%

Packing

Factory Profile

MSDS Download

25 kg drum

Name:

Location:

Brief Introduction:

Key Products:

Zhejiang Excel Pharmaceutical Co., Ltd.

Huangyan, Zhejiang

A GMP compliant producer of APIs and intermediates. Working on several DMFs for its products. A strategiic partner of PharmaVantage

Fexofenadine, Gemfibrozil, Meloxicam, Amiodarone HCl, Nefazodone and intermediates